Literature DB >> 11479681

Origin and evolution of GBV-C/hepatitis G virus and relationships with ancient human migrations.

A Pavesi1.   

Abstract

The GB virus C/hepatitis G virus (GBV-C/HGV) is a newly identified human RNA virus, belonging to the Flaviviridae family. Persistent infection by GBV-C/HGV is common in humans, and genetically divergent isolates have been identified in different parts of the world. Due to the absence of a real pathogenic role of GBV-C/HGV in liver disease and its extremely low mutation rate, this virus is a potential marker to trace prehistoric links between human populations. In this study, origin and evolution of GBV-C/HGV were examined using a set of fully sequenced strains of worldwide origin. A first phylogenetic analysis, addressed to the short (255 nucleotides) NS5A overlapping coding region by the neighbor-joining method, suggested an ancient African origin of GBV-C/HGV. This notion was confirmed when the same analysis was applied to the genomic regions showing the lowest rate of synonymous substitutions, covering one-fourth (2184 nucleotides) of the total coding potential of the virus genome. By using a multivariate statistical method and extending the analysis to the complete coding region, fine details of the evolutionary history of GBV-C/HGV were further elucidated. By this approach, isolates from Southeast Asia appeared to be the most closely related to those of African origin, consistent with a major route of ancient human migrations from Africa to southeastern parts of the Asian continent.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11479681     DOI: 10.1007/s002390010198

Source DB:  PubMed          Journal:  J Mol Evol        ISSN: 0022-2844            Impact factor:   2.395


  16 in total

Review 1.  Role of viruses in human evolution.

Authors:  Linda M Van Blerkom
Journal:  Am J Phys Anthropol       Date:  2003       Impact factor: 2.868

Review 2.  Molecular clocks and the puzzle of RNA virus origins.

Authors:  Edward C Holmes
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

Review 3.  Tropism of human pegivirus (formerly known as GB virus C/hepatitis G virus) and host immunomodulation: insights into a highly successful viral infection.

Authors:  Ernest T Chivero; Jack T Stapleton
Journal:  J Gen Virol       Date:  2015-02-09       Impact factor: 3.891

4.  Evidence against GB virus C infection in dromedary camels.

Authors:  Jack T Stapleton; Donald B Smith; Peter Simmonds
Journal:  Vet Microbiol       Date:  2011-06-30       Impact factor: 3.293

5.  Deep sequencing identifies two genotypes and high viral genetic diversity of human pegivirus (GB virus C) in rural Ugandan patients.

Authors:  Ria R Ghai; Samuel D Sibley; Michael Lauck; Jorge M Dinis; Adam L Bailey; Colin A Chapman; Patrick Omeja; Thomas C Friedrich; David H O'Connor; Tony L Goldberg
Journal:  J Gen Virol       Date:  2013-09-28       Impact factor: 3.891

Review 6.  Mycobacterium leprae: genes, pseudogenes and genetic diversity.

Authors:  Pushpendra Singh; Stewart T Cole
Journal:  Future Microbiol       Date:  2011-01       Impact factor: 3.165

7.  The phylogeography of orangutan foamy viruses supports the theory of ancient repopulation of Sumatra.

Authors:  Ernst J Verschoor; Susan Langenhuijzen; Ilja Bontjer; Zahra Fagrouch; Henk Niphuis; Kristin S Warren; K Eulenberger; Jonathan L Heeney
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

Review 8.  GB virus type C interactions with HIV: the role of envelope glycoproteins.

Authors:  Emma L Mohr; Jack T Stapleton
Journal:  J Viral Hepat       Date:  2009-09-15       Impact factor: 3.728

9.  Bayesian coalescent analysis reveals a high rate of molecular evolution in GB virus C.

Authors:  Camila M Romano; Paolo M de A Zanotto; Edward C Holmes
Journal:  J Mol Evol       Date:  2008-03-05       Impact factor: 2.395

10.  Detecting Traces of Prehistoric Human Migrations by Geographic Synthetic Maps of Polyomavirus JC.

Authors:  Angelo Pavesi
Journal:  J Mol Evol       Date:  2004-03       Impact factor: 2.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.